|
US7517884B2
(en)
*
|
1998-03-30 |
2009-04-14 |
Kalypsys Inc. |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR
|
|
KR20020070285A
(ko)
|
1999-11-23 |
2002-09-05 |
메틸진, 인크. |
히스톤 디아세틸라제의 억제제
|
|
EP1335898B1
(en)
*
|
2000-09-29 |
2005-11-23 |
TopoTarget UK Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
|
CA2423744C
(en)
*
|
2000-09-29 |
2012-04-03 |
Prolifix Limited |
Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
|
|
US6706686B2
(en)
|
2001-09-27 |
2004-03-16 |
The Regents Of The University Of Colorado |
Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
|
|
EP1443928B1
(en)
|
2001-10-16 |
2011-07-27 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases and cancer of the brain
|
|
WO2003075839A2
(en)
|
2002-03-04 |
2003-09-18 |
Aton Pharma, Inc. |
Methods of inducing terminal differentiation
|
|
US7148257B2
(en)
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
|
US7456219B2
(en)
|
2002-03-04 |
2008-11-25 |
Merck Hdac Research, Llc |
Polymorphs of suberoylanilide hydroxamic acid
|
|
CA2479906C
(en)
|
2002-04-03 |
2011-02-08 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7250514B1
(en)
|
2002-10-21 |
2007-07-31 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
TW200418806A
(en)
*
|
2003-01-13 |
2004-10-01 |
Fujisawa Pharmaceutical Co |
HDAC inhibitor
|
|
US7465719B2
(en)
|
2003-01-17 |
2008-12-16 |
Topotarget Uk Limited |
Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitors
|
|
US7652036B2
(en)
|
2003-02-25 |
2010-01-26 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
|
|
CA2518318A1
(en)
|
2003-03-17 |
2004-09-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
SI1611088T1
(sl)
|
2003-04-07 |
2009-12-31 |
Pharmacyclics Inc |
Hidroksamati kot terapevtska sredstva
|
|
EP1641783B1
(en)
*
|
2003-06-19 |
2012-03-28 |
Janssen Pharmaceutica NV |
Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
|
|
DE602004004665T2
(de)
|
2003-08-20 |
2008-01-03 |
Pharmacyclics, Inc., Sunnyvale |
Acetylenderivate als inhibitoren von histondeacetylase
|
|
KR100924737B1
(ko)
|
2003-08-26 |
2009-11-04 |
슬로안-케테링인스티튜트퍼캔서리서치 |
Ｈｄａｃ 억제제를 이용한 암의 치료 방법
|
|
CA2535889A1
(en)
|
2003-08-29 |
2005-03-17 |
Aton Pharma, Inc. |
Combination methods of treating cancer
|
|
WO2005065681A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
|
|
US20050137234A1
(en)
*
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
WO2005061448A1
(en)
*
|
2003-12-24 |
2005-07-07 |
Monash University |
Compositions and methods for treating vascular conditions
|
|
GB0401876D0
(en)
|
2004-01-28 |
2004-03-03 |
Vereniging Het Nl Kanker I |
New use for cancer antigen
|
|
AR048523A1
(es)
*
|
2004-04-07 |
2006-05-03 |
Kalypsys Inc |
Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
|
|
US7868037B2
(en)
|
2004-07-14 |
2011-01-11 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
EP1771169A1
(en)
|
2004-07-14 |
2007-04-11 |
PTC Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
JP2008507518A
(ja)
|
2004-07-22 |
2008-03-13 |
ピーティーシー セラピューティクス，インコーポレーテッド |
Ｃ型肝炎を治療するためのチエノピリジン
|
|
ITMI20041869A1
(it)
|
2004-10-01 |
2005-01-01 |
Dac Srl |
Nuovi inibitori delle istone deacetilasi
|
|
US8242175B2
(en)
|
2004-10-01 |
2012-08-14 |
Dac S.R.L. |
Class of histone deacetylase inhibitors
|
|
US20070190079A1
(en)
*
|
2004-10-29 |
2007-08-16 |
Kalypsys, Inc. |
Methods for the selective modulation of ppar
|
|
MX2007005205A
(es)
*
|
2004-10-29 |
2007-05-11 |
Kalypsys Inc |
Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma.
|
|
JP2008524246A
(ja)
*
|
2004-12-16 |
2008-07-10 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
NZ589276A
(en)
|
2005-02-03 |
2012-06-29 |
Topotarget Uk Ltd |
Combination therapies using hdac inhibitors and erlotinib (tarceva)
|
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
GB0509225D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of enzymatic activity
|
|
US7642253B2
(en)
*
|
2005-05-11 |
2010-01-05 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
CN101189003B
(zh)
|
2005-05-13 |
2012-02-08 |
托波塔吉特英国有限公司 |
Hdac抑制剂的药物制剂
|
|
AU2012213940B2
(en)
*
|
2005-05-13 |
2015-03-26 |
Topotarget Uk Limited |
Pharmaceutical formulations of HDAC inhibitors
|
|
TWI365068B
(en)
|
2005-05-20 |
2012-06-01 |
Merck Sharp & Dohme |
Formulations of suberoylanilide hydroxamic acid and methods for producing same
|
|
EA200800321A1
(ru)
|
2005-07-14 |
2008-06-30 |
Такеда Сан Диего, Инк. |
Ингибиторы гистондеацетилазы
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
EP1928437A2
(en)
|
2005-08-26 |
2008-06-11 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
EP1940815B1
(en)
*
|
2005-10-25 |
2018-08-15 |
Kalypsys, Inc. |
Salts of modulators of ppar and methods of treating metabolic disorders
|
|
US20070112017A1
(en)
|
2005-10-31 |
2007-05-17 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
JP5377968B2
(ja)
|
2005-11-10 |
2013-12-25 |
トポターゲット ユーケー リミテッド |
癌治療のために単独で用いるまたは化学療法薬と併用するヒストンデアセチラーゼ（ｈｄａｃ）阻害剤
|
|
WO2007084390A2
(en)
*
|
2006-01-13 |
2007-07-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20070249519A1
(en)
*
|
2006-04-20 |
2007-10-25 |
Kalypsys, Inc. |
Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease
|
|
WO2007145704A2
(en)
|
2006-04-24 |
2007-12-21 |
Gloucester Pharmaceuticals |
Gemcitabine combination therapy
|
|
WO2007134077A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
AU2007249399A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
TW200745059A
(en)
*
|
2006-05-16 |
2007-12-16 |
Kalypsys Inc |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR
|
|
US8957027B2
(en)
|
2006-06-08 |
2015-02-17 |
Celgene Corporation |
Deacetylase inhibitor therapy
|
|
KR100781467B1
(ko)
*
|
2006-07-13 |
2007-12-03 |
학교법인 포항공과대학교 |
공기중 파라메트릭 트랜스미팅 어레이를 이용한 초지향성초음파 거리측정을 위한 멤스 기반의 다공진 초음파트랜스듀서
|
|
EP2068872A1
(en)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
AU2007296743B2
(en)
*
|
2006-09-11 |
2012-02-16 |
Curis, Inc. |
Tyrosine kinase inhibitors containing a zinc binding moiety
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
GB0619753D0
(en)
|
2006-10-06 |
2006-11-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
US8962825B2
(en)
|
2006-10-30 |
2015-02-24 |
Glaxosmithkline Intellectual Property Development Limited |
Hydroxamates as inhibitors of histone deacetylase
|
|
US8088951B2
(en)
*
|
2006-11-30 |
2012-01-03 |
Massachusetts Institute Of Technology |
Epigenetic mechanisms re-establish access to long-term memory after neuronal loss
|
|
GB0624187D0
(en)
*
|
2006-12-04 |
2007-01-10 |
Jackson William P |
HDAC inhibitors
|
|
RU2446796C2
(ru)
|
2006-12-26 |
2012-04-10 |
Фармасайкликс, Инк. |
Способ использования ингибиторов гистондеацетилазы и мониторинга биомаркеров в комбинированной терапии
|
|
WO2008091863A1
(en)
*
|
2007-01-23 |
2008-07-31 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
|
|
EP2993473A1
(en)
*
|
2007-01-30 |
2016-03-09 |
Pharmacyclics, Inc. |
Methods for determining cancer resistance to histone deacetylase inhibitors
|
|
EP2124916A1
(en)
*
|
2007-02-27 |
2009-12-02 |
Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Use of histone deacetylase inhibitors for the treatment of central nervous system metastases
|
|
EP2135620A4
(en)
|
2007-03-28 |
2010-12-29 |
Santen Pharmaceutical Co Ltd |
AGAINST OKULAR HYPOTONIA CONNECTED TO HISTONE DEACETYLASE INHIBITION AS AN ACTIVE SUBSTANCE
|
|
WO2009036057A1
(en)
*
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Antiproliferative agents containing a zinc binding moiety
|
|
US8008344B2
(en)
*
|
2007-09-14 |
2011-08-30 |
NatureWise Biotech and Medicals Corporation |
Compounds for the inhibition of histone deacetylase
|
|
WO2009042646A1
(en)
*
|
2007-09-24 |
2009-04-02 |
Curis, Inc. |
Anti-proliferative agents
|
|
JP2010540426A
(ja)
*
|
2007-09-25 |
2010-12-24 |
トポターゲット ユーケー リミテッド |
特定のヒドロキサム酸化合物の合成方法
|
|
JP2011501746A
(ja)
*
|
2007-10-10 |
2011-01-13 |
オーキッド リサーチ ラボラトリーズ リミテッド |
新規ヒストンデアセチラーゼインヒビター
|
|
EP2209765A4
(en)
*
|
2007-10-22 |
2010-12-01 |
Orchid Res Lab Ltd |
HISTONE DEACETYLASE INHIBITORS
|
|
US20110044952A1
(en)
*
|
2007-11-27 |
2011-02-24 |
Ottawa Health Research Institute |
Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors
|
|
JP2011517313A
(ja)
|
2007-12-11 |
2011-06-02 |
ビアメト ファーマシューティカルズ，インク． |
金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
|
|
EP2231596A4
(en)
|
2007-12-14 |
2012-06-06 |
Univ Georgetown |
INHIBITORS OF HISTONATE ACETYLASE
|
|
AU2009220942B2
(en)
*
|
2008-03-07 |
2015-05-28 |
Onxeo Dk, Branch Of Onxeo S.A., France |
Methods of treatment employing prolonged continuous infusion of Belinostat
|
|
GB0900555D0
(en)
*
|
2009-01-14 |
2009-02-11 |
Topotarget As |
New methods
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
GB0903480D0
(en)
|
2009-02-27 |
2009-04-08 |
Chroma Therapeutics Ltd |
Enzyme Inhibitors
|
|
KR101168801B1
(ko)
|
2009-03-27 |
2012-07-25 |
주식회사종근당 |
신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물
|
|
US7994357B2
(en)
*
|
2009-04-03 |
2011-08-09 |
Naturewise Biotech & Medicals Corporation |
Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
|
|
ES2473792T3
(es)
|
2009-04-03 |
2014-07-07 |
Naturewise Biotech & Medicals Corporation |
Compuestos cin�micos y derivados de los mismos para la inhibición de la histona desacetilasa
|
|
US8603521B2
(en)
|
2009-04-17 |
2013-12-10 |
Pharmacyclics, Inc. |
Formulations of histone deacetylase inhibitor and uses thereof
|
|
US8901337B2
(en)
|
2009-07-16 |
2014-12-02 |
Royal College Of Surgeons In Ireland |
Metal complexes having dual histone deacetylase inhibitory and DNA-binding activity
|
|
EP2277387B1
(en)
|
2009-07-22 |
2016-10-19 |
NatureWise Biotech & Medicals Corporation |
New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly
|
|
WO2011053876A1
(en)
|
2009-10-30 |
2011-05-05 |
Massachusetts Institute Of Technology |
The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
|
|
WO2011064663A1
(en)
|
2009-11-25 |
2011-06-03 |
Festuccia, Claudio |
Combination treatment employing belinostat and bicalutamide
|
|
US8217079B2
(en)
|
2010-03-26 |
2012-07-10 |
Italfarmaco Spa |
Method for treating Philadelphia-negative myeloproliferative syndromes
|
|
CA2866333C
(en)
|
2011-03-09 |
2020-12-29 |
Cereno Scientific Ab |
Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
|
|
AU2011376953B2
(en)
|
2011-09-13 |
2017-08-24 |
Pharmacyclics Llc |
Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
|
|
WO2013055793A1
(en)
|
2011-10-12 |
2013-04-18 |
University Of Pittsburg-Of The Commonwealth System Of Higher Education |
Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
|
|
WO2013101600A1
(en)
*
|
2011-12-29 |
2013-07-04 |
Pharmacyclics, Inc. |
Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8
|
|
US20150141470A1
(en)
|
2012-05-08 |
2015-05-21 |
The Broad Institute, Inc. |
Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy
|
|
CN102786448B
(zh)
*
|
2012-08-09 |
2014-03-12 |
深圳万乐药业有限公司 |
一种合成belinostat的方法
|
|
US9878986B2
(en)
|
2013-04-29 |
2018-01-30 |
Chong Kun Dang Pharmaceutical Corp. |
Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
|
|
CA2919996A1
(en)
|
2013-08-02 |
2015-02-05 |
Pharmacyclics Llc |
Methods for the treatment of solid tumors
|
|
CA2924527C
(en)
|
2013-09-20 |
2022-07-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Compounds for treating prostate cancer
|
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
WO2015051035A1
(en)
|
2013-10-01 |
2015-04-09 |
The J. David Gladstone Institutes |
Compositions, systems and methods for gene expression noise drug screening and uses thereof
|
|
ES2704704T3
(es)
|
2013-12-12 |
2019-03-19 |
Chong Kun Dang Pharmaceutical Corp |
Nuevos derivados de azaindol como inhibidores selectivos de la histona desacetilasa (HDAC) y composiciones farmacéuticas que los comprenden
|
|
KR101685639B1
(ko)
|
2014-01-03 |
2016-12-12 |
주식회사 종근당 |
신규한 인돌 유도체 화합물 및 이를 포함하는 약제학적 조성물
|
|
EP3223816B1
(en)
|
2014-11-26 |
2020-04-22 |
The J. David Gladstone Institutes |
Methods for treating a cytomegalovirus infection
|
|
CN104478769B
(zh)
*
|
2014-12-22 |
2016-01-06 |
深圳万乐药业有限公司 |
一种适合工业化生产的贝利司他合成方法
|
|
US9745253B2
(en)
*
|
2015-03-13 |
2017-08-29 |
Forma Therapeutics, Inc. |
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
|
|
JP6507267B2
(ja)
|
2015-05-22 |
2019-04-24 |
チョン クン ダン ファーマシューティカル コーポレーション |
選択的ヒストンデアセチラーゼ阻害剤としてのヘテロ環状アルキル誘導体化合物及びこれを含有する薬剤学的組成物
|
|
WO2016205203A1
(en)
|
2015-06-16 |
2016-12-22 |
Spectrum Pharmaceuticals, Inc. |
Combination therapy using belinostat and pralatrexate to treat lymphoma
|
|
CN105646297B
(zh)
*
|
2015-09-06 |
2017-12-29 |
杨东 |
一种生产贝利司他中间体的工艺方法
|
|
CN105237444B
(zh)
*
|
2015-09-24 |
2018-03-30 |
沈阳药科大学 |
异羟肟酸类化合物及其制备方法和用途
|
|
ITUB20155193A1
(it)
|
2015-11-03 |
2017-05-03 |
Italfarmaco Spa |
Sospensioni orali di Givinostat fisicamente e chimicamente stabili
|
|
CN105367455B
(zh)
*
|
2015-12-18 |
2017-10-24 |
深圳万乐药业有限公司 |
一种贝利司他异构体的制备方法
|
|
CN105481736A
(zh)
*
|
2015-12-28 |
2016-04-13 |
山东大学 |
一种含有苯甘氨酸的肉桂酰胺类组蛋白去乙酰化酶抑制剂及其制备方法和应用
|
|
WO2017144548A1
(en)
|
2016-02-22 |
2017-08-31 |
Onxeo |
Combination therapies comprising immuno-oncology agents and doxorubicin-loaded poly(cyanoacrylate) nanoparticles
|
|
CN108349882B
(zh)
*
|
2016-03-04 |
2020-09-18 |
深圳市塔吉瑞生物医药有限公司 |
一种取代的丙烯酰胺化合物及其药物组合物
|
|
US10980806B2
(en)
|
2016-03-24 |
2021-04-20 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
CN105732444B
(zh)
*
|
2016-03-28 |
2018-01-30 |
大连理工大学 |
一种贝利司他的合成方法
|
|
US20190256459A1
(en)
*
|
2016-05-17 |
2019-08-22 |
Biophore India Pharmaceuticals Pvt. Ltd. |
Novel process for the preparation of belinostat
|
|
WO2018015493A1
(en)
|
2016-07-20 |
2018-01-25 |
Royal College Of Surgeons In Ireland |
Metal complexes having therapeutic applications
|
|
ES2879294T3
(es)
|
2016-07-26 |
2021-11-22 |
Fresenius Kabi Oncology Ltd |
Formas polimórficas de Belinostat y procesos para la preparación de las mismas
|
|
WO2018054960A1
(en)
|
2016-09-21 |
2018-03-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting and treating resistance to chemotherapy in npm-alk(+) alcl
|
|
WO2018165520A1
(en)
|
2017-03-10 |
2018-09-13 |
Vps-3, Inc. |
Metalloenzyme inhibitor compounds
|
|
EA039150B1
(ru)
|
2017-07-03 |
2021-12-10 |
Онксео |
Новые пероральные составы на основе белиностата
|
|
EP3461480A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
|
|
EP3461488A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dbait molecule and a hdac inhibitor for treating cancer
|
|
RU2748835C1
(ru)
|
2017-11-27 |
2021-05-31 |
Совет Научных И Прикладных Исследований |
Индол(сульфонил)-n-гидроксибензамидные производные в качестве селективных ингибиторов hdac
|
|
US12606829B2
(en)
|
2018-06-12 |
2026-04-21 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Compositions for herpesvirus transcriptional feedback circuit disruption and uses thereof
|
|
WO2020102599A1
(en)
*
|
2018-11-14 |
2020-05-22 |
Vanderbilt University |
Treating intraocular retinoblastoma with inhibitors of histone modification
|
|
WO2020186101A1
(en)
|
2019-03-12 |
2020-09-17 |
The Broad Institute, Inc. |
Detection means, compositions and methods for modulating synovial sarcoma cells
|
|
CN111848591B
(zh)
*
|
2019-04-25 |
2022-03-18 |
成都先导药物开发股份有限公司 |
Hdac抑制剂及其制备方法和用途
|
|
AU2020321955A1
(en)
|
2019-07-30 |
2022-03-17 |
Eikonizo Therapapeutics, Inc. |
HDAC6 inhibitors and uses thereof
|
|
WO2021148581A1
(en)
|
2020-01-22 |
2021-07-29 |
Onxeo |
Novel dbait molecule and its use
|
|
EP4405680A1
(en)
|
2021-09-20 |
2024-07-31 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
|
|
EP4504165A1
(en)
|
2022-04-05 |
2025-02-12 |
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale |
Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer
|
|
IL316201A
(en)
|
2022-04-08 |
2024-12-01 |
Eikonizo Therapeutics Inc |
Oxadiazole HDAC6 inhibitors and their uses
|
|
CN115636774B
(zh)
*
|
2022-12-01 |
2023-12-22 |
南开大学 |
一种贝利司他的合成方法
|
|
WO2024184266A1
(en)
|
2023-03-03 |
2024-09-12 |
Ionctura Sa |
Combination of roginolisib and hdac inhibitor in the treatment of haematological malignancy
|
|
WO2025026925A1
(en)
|
2023-07-28 |
2025-02-06 |
Ospedale San Raffaele S.R.L. |
Gtf2i inhibitors and uses thereof
|
|
WO2025257171A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|
|
WO2025257176A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|
|
WO2025257173A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|